Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza to treat mild to moderate Covid-19 patients.
Favipiravir is an off patent, oral antiviral drug that has been shown to hasten clinical recovery in Covid-19 patients with mild to moderate symptoms.
Regarding the availability date and cost, Cipla said it will commercially launch Ciplenza in the first week of August priced at Rs 68 per tablet.
The price of Favipiravir has become a matter of great concern in the country as Glenmark Pharmaceuticals faced flak after it initially launched its Favipiravir drug under the brand name FabiFlu at Rs 103 per tablet.
Subsequently on July 13, Glenmark reduced the price of FabiFlu to Rs 75 per tablet.
Cipla said to ensure fair and equitable distribution of the drug, supplies will be undertaken predominantly through hospital channels and via open channels, prioritised for regions with a high burden of Covid-19 cases.
The drug has been jointly developed by Cipla and CSIR-Indian Institute of Chemical Technology (IICT).
As part of this partnership, CSIR-IICT has successfully developed a convenient and cost-effective synthetic process for Favipiravir.
The entire process and active pharmaceutical ingredient (API) of the drug has been transferred to Cipla to manufacture and market the drug at scale.
Towards providing drugs for coronavirus patients in India, CSIR late in April said it had identified top 25 drugs/drug candidates for repurposing.
Among these top 25 drugs, Favipiravir, a broad spectrum inhibitor of viral RNA polymerase emerged as one of the most promising drugs.
Favipiravir was developed by Fujifilm Toyama Chemical Ltd., and is used for treatment of common influenza in some markets.
For all the latest News, Opinions and Views, download ummid.com App.
Select Language To Read in Urdu, Hindi, Marathi or Arabic.
CBSE 12th 2020 Topper Areeba credits her success to sister, a 2019 Ranker
Stunning Aviator Sunglasses that will help you stand out
Gandhi had dubbed Dadabhai Naoroji Father of the Nation, Mahatma
Eid al-Adha 2020 in India, Bangladesh and Pakistan on August 1
Also Read
Eid al-Adha 2020 in Saudi Arabia on July 31; Hajj 2020 on July 30
12,854 deaths, 140,092 active cases; Maharashtra Corona situation still alarming
Gujarat now has 52,563 Covid-19 cases, check districtwise situation today
'Outrageous': Protest over Police case against students appearing for KEAM 2020
Will reopening schools bring herd immunity in India? Experts debate
Teachers sue Florida Governor over school reopening amid Corona scare
Now, Malegaon Civic Chief in dock over denial of salaries to Covid hosp staff
Malegaon Corporation withdraws order threatening Corona warrior after outrage
Hagia Sophia: Has Erdoğan failed his litmus test?
'Open Provocation': World reacts to Erdogan reconverting Hagia Sophia into a mosque
Istanbul's Hagia Sophia mosque reverberates with Azaan after 85 years
'And, we are busy constructing temples': Ex-IAS officer as India's Health System crumbles
Containing Covid spread in monsoon, winter will be challenging: IIT-AIIMS study
